{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T22:04:05Z","timestamp":1767218645260,"version":"3.48.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH CounterACT Program","award":["UG3 NS133630"],"award-info":[{"award-number":["UG3 NS133630"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Lethal organophosphate (OP) exposure leads to status epilepticus (SE), which, despite standard-of-care (SOC) therapy, is associated with acute mortality and long-term morbidities. Neuronal injury and inflammation are reported following OP-SE, and drugs targeted at these processes have produced beneficial outcomes. Verapamil (VPM) is a calcium-channel blocker used as an antihypertensive drug and has been shown to exhibit neuroprotective and anti-inflammatory actions in experimental models of CNS injuries. Here, we investigated the feasibility of an adjunctive intramuscular (i.m.) VPM therapy in OP Diisopropyl Fluorophosphate (DFP)-induced SE. We also investigated the safety and toxicity of i.m. VPM and compared its pharmacokinetic (PK) profile to oral (p.o.) administration. Rats were injected with DFP (4\u00a0mg\/kg, s.c.). One minute later, SOC treatment consisting of atropine (0.5\u00a0mg\/kg, i.m.) and pralidoxime chloride (2-PAM; 25\u00a0mg\/kg, i.m.) were administered, and at 1-hour post-SE, midazolam (1.78\u00a0mg\/kg, i.m.) was given. Rats that met the behavioral SE severity criteria (Racine 4\u20135) were randomized into two treatment groups: those receiving saline (SAL) or VPM (10\u00a0mg\/kg, i.m.\n                    <jats:italic>bid<\/jats:italic>\n                    , 3 days). Histological analysis was conducted to assess neuronal injury and injection-site pathology. In a separate group of rats, PK studies were conducted on blood and brain homogenates treated once with saline or VPM (10\u00a0mg\/kg, p.o. or i.m.). Our data demonstrated that following DFP-SE, i.m. VPM achieved higher blood and brain levels and exhibited a favorable PK profile compared to p.o. route. VPM therapy did not cause significant muscle pathology and produced a robust neuroprotective response. Neuroinflammatory markers and long-term behavioral outcomes were not included in this study. Our studies provide evidence that the i.m. route is an effective method for delivering VPM following SE, producing significant neuroprotective outcomes compared to treatment with the standard-of-care alone in OP-SE.\n                  <\/jats:p>","DOI":"10.1007\/s12640-025-00765-z","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T04:58:12Z","timestamp":1760763492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of Intramuscular Verapamil as Pharmacological Countermeasure in a Rat Model of Organophosphate DFP-induced Status Epilepticus"],"prefix":"10.1007","volume":"43","author":[{"given":"Yam Nath","family":"Paudel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew S.","family":"Halquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Funderburk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Calvano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Koblinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hope","family":"Richard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laxmikant S.","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,18]]},"reference":[{"issue":"9","key":"765_CR1","doi-asserted-by":"publisher","first-page":"726","DOI":"10.2471\/BLT.07.043489","volume":"86","author":"V Ajdacic-Gross","year":"2008","unstructured":"Ajdacic-Gross V, Weiss MG, Ring M, Hepp U, Bopp M, Gutzwiller F, Rossler W (2008) Methods of suicide: international suicide patterns derived from the WHO mortality database. Bull World Health Organ 86(9):726\u2013732","journal-title":"Bull World Health Organ"},{"issue":"24","key":"765_CR2","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","volume":"64","author":"EA Amsterdam","year":"2014","unstructured":"Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr., Ganiats TG, Holmes DR Jr., Jaffe AS, Jneid H, Kelly RF, Kontos MC, Levine GN, Liebson PR, Mukherjee D, Peterson ED, Sabatine MS, Smalling RW, Zieman SJ (2014) 2014 AHA\/ACC guideline for the management of patients with Non-ST-Elevation acute coronary syndromes: a report of the American college of Cardiology\/American heart association task force on practice guidelines. J Am Coll Cardiol 64(24):e139\u2013e228. https:\/\/doi.org\/10.1016\/j.jacc.2014.09.017","journal-title":"J Am Coll Cardiol"},{"key":"765_CR3","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.neuro.2020.01.012","volume":"77","author":"WK Anger","year":"2020","unstructured":"Anger WK, Farahat FM, Lein PJ, Lasarev MR, Olson JR, Farahat TM, Rohlman DS (2020) Magnitude of behavioral deficits varies with job-related Chlorpyrifos exposure levels among Egyptian pesticide workers. Neurotoxicology 77:216\u2013230. https:\/\/doi.org\/10.1016\/j.neuro.2020.01.012","journal-title":"Neurotoxicology"},{"key":"765_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/toxics11100866","author":"V Aroniadou-Anderjaska","year":"2023","unstructured":"Aroniadou-Anderjaska V, Figueiredo TH, de Araujo Furtado M, Pidoplichko VI, Braga MFM (2023) Mechanisms of organophosphate toxicity and the role of acetylcholinesterase inhibition. Toxics. https:\/\/doi.org\/10.3390\/toxics11100866","journal-title":"Toxics"},{"key":"765_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0065-2423(04)38006-6","volume":"38","author":"J Bajgar","year":"2004","unstructured":"Bajgar J (2004) Organophosphates\/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 38:151\u2013216","journal-title":"Adv Clin Chem"},{"key":"765_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106316","volume":"187","author":"PN Bernardino","year":"2023","unstructured":"Bernardino PN, Hobson BA, Huddleston SL, Andrew PM, MacMahon JA, Saito NH, Porter VA, Bruun DA, Harvey DJ, Garbow JR, Gelli A, Chaudhari AJ, Lein PJ (2023) Time- and region-dependent blood-brain barrier impairment in a rat model of organophosphate-induced status epilepticus. Neurobiol Dis 187:106316. https:\/\/doi.org\/10.1016\/j.nbd.2023.106316","journal-title":"Neurobiol Dis"},{"issue":"2","key":"765_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1124\/jpet.123.001836","volume":"388","author":"PN Bernardino","year":"2024","unstructured":"Bernardino PN, Luo AS, Andrew PM, Unkel CM, Gonzalez MI, Gelli A, Lein PJ (2024) Evidence implicating blood-brain barrier impairment in the pathogenesis of acquired epilepsy following acute organophosphate intoxication. J Pharmacol Exp Ther 388(2):301\u2013312. https:\/\/doi.org\/10.1124\/jpet.123.001836","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"765_CR8","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S1474-4422(15)00042-3","volume":"14","author":"JP Betjemann","year":"2015","unstructured":"Betjemann JP, Lowenstein DH (2015) Status epilepticus in adults. Lancet Neurol 14(6):615\u2013624. https:\/\/doi.org\/10.1016\/S1474-4422(15)00042-3","journal-title":"Lancet Neurol"},{"issue":"2","key":"765_CR9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1124\/jpet.123.001739","volume":"388","author":"RE Blair","year":"2024","unstructured":"Blair RE, Hawkins E, Pinchbeck LR, DeLorenzo RJ, Deshpande LS (2024) Chronic epilepsy and mossy fiber sprouting following organophosphate-induced status epilepticus in rats. J Pharmacol Exp Ther 388(2):325\u2013332. https:\/\/doi.org\/10.1124\/jpet.123.001739","journal-title":"J Pharmacol Exp Ther"},{"key":"765_CR10","unstructured":"Chemical Hazards Emergency Medical Management (2013) Nerve Agents - Emergency Department\/Hospital Management"},{"key":"765_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16173147","author":"CS Chuang","year":"2019","unstructured":"Chuang CS, Yang KW, Yen CM, Lin CL, Kao CH (2019) Risk of seizures in patients with organophosphate poisoning: a nationwide population-based study. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph16173147","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"765_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/toxsci\/kfx266","volume":"162","author":"LG Costa","year":"2018","unstructured":"Costa LG (2018) Organophosphorus compounds at 80: some old and new issues. Toxicol Sci 162(1):24\u201335. https:\/\/doi.org\/10.1093\/toxsci\/kfx266","journal-title":"Toxicol Sci"},{"key":"765_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.03.006","volume":"133","author":"LS Deshpande","year":"2020","unstructured":"Deshpande LS, DeLorenzo RJ (2020) Novel therapeutics for treating organophosphate-induced status epilepticus co-morbidities, based on changes in calcium homeostasis. Neurobiol Dis 133:104418. https:\/\/doi.org\/10.1016\/j.nbd.2019.03.006","journal-title":"Neurobiol Dis"},{"issue":"2","key":"765_CR14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/toxsci\/kfq157","volume":"116","author":"LS Deshpande","year":"2010","unstructured":"Deshpande LS, Carter DS, Blair RE, DeLorenzo RJ (2010) Development of a prolonged calcium plateau in hippocampal neurons in rats surviving status epilepticus induced by the organophosphate diisopropylfluorophosphate. Toxicol Sci 116(2):623\u2013631. https:\/\/doi.org\/10.1093\/toxsci\/kfq157","journal-title":"Toxicol Sci"},{"key":"765_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neuro.2014.04.006","volume":"44","author":"LS Deshpande","year":"2014","unstructured":"Deshpande LS, Carter DS, Phillips KF, Blair RE, DeLorenzo RJ (2014) Development of status epilepticus, sustained calcium elevations and neuronal injury in a rat survival model of lethal Paraoxon intoxication. Neurotoxicology 44:17\u201326. https:\/\/doi.org\/10.1016\/j.neuro.2014.04.006","journal-title":"Neurotoxicology"},{"key":"765_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ntt.2016.05.002","volume":"56","author":"LS Deshpande","year":"2016","unstructured":"Deshpande LS, Blair RE, Huang BA, Phillips KF, DeLorenzo RJ (2016) Pharmacological blockade of the calcium plateau provides neuroprotection following organophosphate Paraoxon induced status epilepticus in rats. Neurotoxicol Teratol 56:81\u201386. https:\/\/doi.org\/10.1016\/j.ntt.2016.05.002","journal-title":"Neurotoxicol Teratol"},{"issue":"1","key":"765_CR17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/nyas.14500","volume":"1480","author":"LS Deshpande","year":"2020","unstructured":"Deshpande LS, Blair RE, Halquist M, Kosmider L, DeLorenzo RJ (2020) Intramuscular Atenolol and Levetiracetam reduce mortality in a rat model of paraoxon-induced status epilepticus. Ann N Y Acad Sci 1480(1):219\u2013232. https:\/\/doi.org\/10.1111\/nyas.14500","journal-title":"Ann N Y Acad Sci"},{"issue":"9612","key":"765_CR18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0140-6736(07)61202-1","volume":"371","author":"M Eddleston","year":"2008","unstructured":"Eddleston M, Buckley NA, Eyer P, Dawson AH (2008) Management of acute organophosphorus pesticide poisoning. Lancet 371(9612):597\u2013607. https:\/\/doi.org\/10.1016\/S0140-6736(07)61202-1","journal-title":"Lancet"},{"key":"765_CR19","volume-title":"Verapamil","author":"S Fahie","year":"2022","unstructured":"Fahie S, Cassagnol M (2022) Verapamil. StatPearls, Treasure Island (FL)"},{"issue":"1","key":"765_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neuint.2012.10.012","volume":"62","author":"W Fang","year":"2013","unstructured":"Fang W, Lv P, Geng X, Shang E, Yang Q, Sha L, Li Y (2013) Penetration of verapamil across blood brain barrier following cerebral ischemia depending on both paracellular pathway and P-glycoprotein transportation. Neurochem Int 62(1):23\u201330. https:\/\/doi.org\/10.1016\/j.neuint.2012.10.012","journal-title":"Neurochem Int"},{"issue":"1","key":"765_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0744-y","volume":"13","author":"BM Flannery","year":"2016","unstructured":"Flannery BM, Bruun DA, Rowland DJ, Banks CN, Austin AT, Kukis DL, Li Y, Ford BD, Tancredi DJ, Silverman JL, Cherry SR, Lein PJ (2016) Persistent neuroinflammation and cognitive impairment in a rat model of acute diisopropylfluorophosphate intoxication. J Neuroinflammation 13(1):267. https:\/\/doi.org\/10.1186\/s12974-016-0744-y","journal-title":"J Neuroinflammation"},{"issue":"Suppl 2","key":"765_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1365-2125.1986.tb02864.x","volume":"21","author":"F Follath","year":"1986","unstructured":"Follath F, Ha HR, Schutz E, Buhler F (1986) Pharmacokinetics of conventional and slow-release verapamil. Br J Clin Pharmacol 21(Suppl 2):149\u2013153. https:\/\/doi.org\/10.1111\/j.1365-2125.1986.tb02864.x","journal-title":"Br J Clin Pharmacol"},{"key":"765_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11010061","author":"M Gage","year":"2021","unstructured":"Gage M, Putra M, Wachter L, Dishman K, Gard M, Gomez-Estrada C, Thippeswamy T (2021) Saracatinib, a Src tyrosine kinase inhibitor, as a disease modifier in the rat DFP model: sex differences, neurobehavior, gliosis, neurodegeneration, and nitro-oxidative stress. Antioxidants. https:\/\/doi.org\/10.3390\/antiox11010061","journal-title":"Antioxidants"},{"issue":"2","key":"765_CR24","first-page":"105","volume":"38","author":"B George","year":"2000","unstructured":"George B, Kulkarni SK, Mathur R (2000) Motor and electrographic response of refractory experimental status epilepticus in rats and effect of calcium channel blockers. Indian J Exp Biol 38(2):105\u2013112","journal-title":"Indian J Exp Biol"},{"key":"765_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.crtox.2021.09.002","volume":"2","author":"EA Gonzalez","year":"2021","unstructured":"Gonzalez EA, Calsbeek JJ, Tsai YH, Tang MY, Andrew P, Vu J, Berg EL, Saito NH, Harvey DJ, Supasai S, Gurkoff GG, Silverman JL, Lein PJ (2021) Sex-specific acute and chronic neurotoxicity of acute diisopropylfluorophosphate (DFP)-intoxication in juvenile Sprague-Dawley rats. Curr Res Toxicol 2:341\u2013356. https:\/\/doi.org\/10.1016\/j.crtox.2021.09.002","journal-title":"Curr Res Toxicol"},{"key":"765_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.03.019","volume":"133","author":"M Guignet","year":"2020","unstructured":"Guignet M, Dhakal K, Flannery BM, Hobson BA, Zolkowska D, Dhir A, Bruun DA, Li S, Wahab A, Harvey DJ, Silverman JL, Rogawski MA, Lein PJ (2020) Persistent behavior deficits, neuroinflammation, and oxidative stress in a rat model of acute organophosphate intoxication. Neurobiol Dis 133:104431. https:\/\/doi.org\/10.1016\/j.nbd.2019.03.019","journal-title":"Neurobiol Dis"},{"issue":"Suppl 8","key":"765_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1528-1167.2007.01360.x","volume":"48","author":"C Helmstaedter","year":"2007","unstructured":"Helmstaedter C (2007) Cognitive outcome of status epilepticus in adults. Epilepsia 48(Suppl 8):85\u201390","journal-title":"Epilepsia"},{"issue":"10","key":"765_CR28","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.2337\/db18-0008","volume":"67","author":"DA Jackson","year":"2018","unstructured":"Jackson DA, Michael T, Vieira de Abreu A, Agrawal R, Bortolato M, Fisher SJ (2018) Prevention of severe Hypoglycemia-Induced brain damage and cognitive impairment with verapamil. Diabetes 67(10):2107\u20132112. https:\/\/doi.org\/10.2337\/db18-0008","journal-title":"Diabetes"},{"issue":"3","key":"765_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1590\/s1020-49892003000800004","volume":"14","author":"K Jaga","year":"2003","unstructured":"Jaga K, Dharmani C (2003) Sources of exposure to and public health implications of organophosphate pesticides. Rev Panam Salud Publica 14(3):171\u2013185. https:\/\/doi.org\/10.1590\/s1020-49892003000800004","journal-title":"Rev Panam Salud Publica"},{"key":"765_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5872645","volume":"2020","author":"E Jangholi","year":"2020","unstructured":"Jangholi E, Sharifi ZN, Hoseinian M, Zarrindast MR, Rahimi HR, Mowla A, Aryan H, Javidi MA, Parsa Y, Ghaffarpasand F, Yadollah-Damavandi S, Arani HZ, Shahi F, Movassaghi S (2020) Verapamil inhibits mitochondria-induced reactive oxygen species and dependent apoptosis pathways in cerebral transient global ischemia\/reperfusion. Oxid Med Cell Longev 2020:5872645. https:\/\/doi.org\/10.1155\/2020\/5872645","journal-title":"Oxid Med Cell Longev"},{"issue":"23","key":"765_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3000752","volume":"2","author":"DA Jett","year":"2010","unstructured":"Jett DA (2010) Finding new cures for neurological disorders: a possible fringe benefit of biodefense research? Sci Transl Med 2(23):23ps12. https:\/\/doi.org\/10.1126\/scitranslmed.3000752","journal-title":"Sci Transl Med"},{"issue":"4","key":"765_CR32","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/15376516.2019.1669250","volume":"31","author":"DA Jett","year":"2021","unstructured":"Jett DA, Laney JW (2021) Civilian research on chemical medical countermeasures. Toxicol Mech Methods 31(4):242\u2013243. https:\/\/doi.org\/10.1080\/15376516.2019.1669250","journal-title":"Toxicol Mech Methods"},{"key":"765_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2018.11.020","volume":"133","author":"DA Jett","year":"2020","unstructured":"Jett DA, Spriggs SM (2020) Translational research on chemical nerve agents. Neurobiol Dis 133:104335. https:\/\/doi.org\/10.1016\/j.nbd.2018.11.020","journal-title":"Neurobiol Dis"},{"issue":"10","key":"765_CR34","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.3174\/ajnr.A2183","volume":"31","author":"P Jun","year":"2010","unstructured":"Jun P, Ko NU, English JD, Dowd CF, Halbach VV, Higashida RT, Lawton MT, Hetts SW (2010) Endovascular treatment of medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol 31(10):1911\u20131916. https:\/\/doi.org\/10.3174\/ajnr.A2183","journal-title":"AJNR Am J Neuroradiol"},{"key":"765_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2024.109918","volume":"158","author":"L Kamppi","year":"2024","unstructured":"Kamppi L, Kamppi A, Strzelczyk A (2024) Mortality and morbidity of status epilepticus over the long term. Epilepsy Behav 158:109918. https:\/\/doi.org\/10.1016\/j.yebeh.2024.109918","journal-title":"Epilepsy Behav"},{"issue":"14","key":"765_CR36","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1001\/jama.247.14.1911","volume":"247","author":"J Kangilaski","year":"1982","unstructured":"Kangilaski J, McBride G (1982) Calcium blockers for heart disease: two approved, more to come. JAMA 247(14):1911\u201319131917. https:\/\/doi.org\/10.1001\/jama.247.14.1911","journal-title":"JAMA"},{"issue":"11","key":"765_CR37","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1096\/fj.14.11.1508","volume":"14","author":"HS Kim","year":"2000","unstructured":"Kim HS, Park CH, Cha SH, Lee JH, Lee S, Kim Y, Rah JC, Jeong SJ, Suh YH (2000) Carboxyl-terminal fragment of alzheimer\u2019s APP destabilizes calcium homeostasis and renders neuronal cells vulnerable to excitotoxicity. FASEB J 14(11):1508\u20131517. https:\/\/doi.org\/10.1096\/fj.14.11.1508","journal-title":"FASEB J"},{"key":"765_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2024.116870","volume":"484","author":"S Lazar","year":"2024","unstructured":"Lazar S, Neufeld-Cohen A, Egoz I, Baranes S, Gez R, Glick P, Cohen M, Gutman H, Chapman S, Gore A (2024) Efficacy of a combined anti-seizure treatment against cholinergic established status epilepticus following a sarin nerve agent insult in rats. Toxicol Appl Pharmacol 484:116870. https:\/\/doi.org\/10.1016\/j.taap.2024.116870","journal-title":"Toxicol Appl Pharmacol"},{"key":"765_CR39","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bcp.2016.08.013","volume":"118","author":"KV Ledwitch","year":"2016","unstructured":"Ledwitch KV, Gibbs ME, Barnes RW, Roberts AG (2016) Cooperativity between verapamil and ATP bound to the efflux transporter P-glycoprotein. Biochem Pharmacol 118:96\u2013108. https:\/\/doi.org\/10.1016\/j.bcp.2016.08.013","journal-title":"Biochem Pharmacol"},{"key":"765_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuro.2018.08.011","volume":"69","author":"JD Lewine","year":"2018","unstructured":"Lewine JD, Weber W, Gigliotti A, McDonald JD, Doyle-Eisele M, Bangera N, Paulson K, Magcalas C, Hamilton DA, Garcia E, Raulli R, Laney J (2018) Addition of ketamine to standard-of-care countermeasures for acute organophosphate poisoning improves neurobiological outcomes. Neurotoxicology 69:37\u201346. https:\/\/doi.org\/10.1016\/j.neuro.2018.08.011","journal-title":"Neurotoxicology"},{"issue":"3","key":"765_CR41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.taap.2011.03.026","volume":"253","author":"Y Li","year":"2011","unstructured":"Li Y, Lein PJ, Liu C, Bruun DA, Tewolde T, Ford G, Ford BD (2011) Spatiotemporal pattern of neuronal injury induced by DFP in rats: a model for delayed neuronal cell death following acute OP intoxication. Toxicol Appl Pharmacol 253(3):261\u2013269. https:\/\/doi.org\/10.1016\/j.taap.2011.03.026","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2\u20133","key":"765_CR42","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.neuropharm.2010.10.002","volume":"60","author":"Y Liu","year":"2011","unstructured":"Liu Y, Lo YC, Qian L, Crews FT, Wilson B, Chen HL, Wu HM, Chen SH, Wei K, Lu RB, Ali S, Hong JS (2011) Verapamil protects dopaminergic neuron damage through a novel anti-inflammatory mechanism by inhibition of microglial activation. Neuropharmacology 60(2\u20133):373\u2013380. https:\/\/doi.org\/10.1016\/j.neuropharm.2010.10.002","journal-title":"Neuropharmacology"},{"issue":"4","key":"765_CR43","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1177\/0271678X15608395","volume":"36","author":"ME Maniskas","year":"2016","unstructured":"Maniskas ME, Roberts JM, Aron I, Fraser JF, Bix GJ (2016) Stroke neuroprotection revisited: intra-arterial verapamil is profoundly neuroprotective in experimental acute ischemic stroke. J Cereb Blood Flow Metab 36(4):721\u2013730. https:\/\/doi.org\/10.1177\/0271678X15608395","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"765_CR44","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/clpt.1982.54","volume":"31","author":"RG McAllister Jr.","year":"1982","unstructured":"McAllister RG Jr., Kirsten EB (1982) The pharmacology of verapamil. IV. Kinetic and dynamic effects after single intravenous and oral doses. Clin Pharmacol Ther 31(4):418\u2013426. https:\/\/doi.org\/10.1038\/clpt.1982.54","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"765_CR45","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3109\/09540261.2014.924094","volume":"26","author":"R Mohanraj","year":"2014","unstructured":"Mohanraj R, Kumar S, Manikandan S, Kannaiyan V, Vijayakumar L (2014) A public health initiative for reducing access to pesticides as a means to committing suicide: findings from a qualitative study. Int Rev Psychiatry 26(4):445\u2013452. https:\/\/doi.org\/10.3109\/09540261.2014.924094","journal-title":"Int Rev Psychiatry"},{"issue":"2","key":"765_CR46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S (2016) A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 7(2):27\u201331. https:\/\/doi.org\/10.4103\/0976-0105.177703","journal-title":"J Basic Clin Pharm"},{"key":"765_CR47","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.tox.2018.08.011","volume":"408","author":"SX Naughton","year":"2018","unstructured":"Naughton SX, Terry AV Jr (2018) Neurotoxicity in acute and repeated organophosphate exposure. Toxicology 408:101\u2013112. https:\/\/doi.org\/10.1016\/j.tox.2018.08.011","journal-title":"Toxicology"},{"issue":"3","key":"765_CR48","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1365-2885.2008.00948.x","volume":"31","author":"EE Patterson","year":"2008","unstructured":"Patterson EE, Goel V, Cloyd JC, O\u2019Brien TD, Fisher JE, Dunn AW, Leppik IE (2008) Intramuscular, intravenous and oral levetiracetam in dogs: safety and pharmacokinetics. J Vet Pharmacol Ther 31(3):253\u2013258. https:\/\/doi.org\/10.1111\/j.1365-2885.2008.00948.x","journal-title":"J Vet Pharmacol Ther"},{"key":"765_CR49","unstructured":"Paxinos G, Watson C (2006) The rat brain in stereotaxic coordinates: hard cover edition. Elsevier"},{"issue":"2","key":"765_CR50","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0165-0270(80)90021-7","volume":"3","author":"G Paxinos","year":"1980","unstructured":"Paxinos G, Watson CR, Emson PC (1980) AChE-stained horizontal sections of the rat brain in stereotaxic coordinates. J Neurosci Methods 3(2):129\u2013149. https:\/\/doi.org\/10.1016\/0165-0270(80)90021-7","journal-title":"J Neurosci Methods"},{"key":"765_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.04.013","volume":"133","author":"JN Pearson-Smith","year":"2020","unstructured":"Pearson-Smith JN, Patel M (2020) Antioxidant drug therapy as a neuroprotective countermeasure of nerve agent toxicity. Neurobiol Dis 133:104457. https:\/\/doi.org\/10.1016\/j.nbd.2019.04.013","journal-title":"Neurobiol Dis"},{"issue":"3","key":"765_CR52","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0013-4694(72)90176-9","volume":"32","author":"RJ Racine","year":"1972","unstructured":"Racine RJ (1972a) Modification of seizure activity by electrical stimulation. I. After- discharge threshold. Electroencephalogr Clin Neurophysiol 32(3):269\u2013279","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"3","key":"765_CR53","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","volume":"32","author":"RJ Racine","year":"1972","unstructured":"Racine RJ (1972b) Modification of seizure activity by electrical stimulation. Part II. Motor seizure. Electroencephalogr Clin Neurophysiol 32(3):281\u2013294","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"5","key":"765_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpet.2025.103555","volume":"392","author":"S Ramakrishnan","year":"2025","unstructured":"Ramakrishnan S, Singh T, Chen A, Wu X, Reddy DS (2025) Neurosteroid mitigation of developmental neurological dysfunction, long-term epileptic biomarkers, chronic neuroinflammation, and neurodegeneration in a pediatric rat model of organophosphate exposure. J Pharmacol Exp Ther 392(5):103555. https:\/\/doi.org\/10.1016\/j.jpet.2025.103555","journal-title":"J Pharmacol Exp Ther"},{"key":"765_CR55","doi-asserted-by":"publisher","first-page":"895092","DOI":"10.3389\/fcell.2022.895092","volume":"10","author":"NS Rao","year":"2022","unstructured":"Rao NS, Meyer C, Vasanthi SS, Massey N, Samidurai M, Gage M, Putra M, Almanza AN, Wachter L, Thippeswamy T (2022) DFP-Induced status epilepticus severity in Mixed-Sex cohorts of adult rats housed in the same room: behavioral and EEG comparisons. Front Cell Dev Biol 10:895092. https:\/\/doi.org\/10.3389\/fcell.2022.895092","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"765_CR56","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22(3):659\u2013661. https:\/\/doi.org\/10.1096\/fj.07-9574LSF","journal-title":"FASEB J"},{"key":"765_CR57","doi-asserted-by":"publisher","first-page":"108571","DOI":"10.1016\/j.neuropharm.2021.108571","volume":"191","author":"DS Reddy","year":"2021","unstructured":"Reddy DS, Zaayman M, Kuruba R, Wu X (2021) Comparative profile of refractory status epilepticus models following exposure of cholinergic agents pilocarpine, DFP, and Soman. Neuropharmacology 191:108571. https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108571","journal-title":"Neuropharmacology"},{"key":"765_CR58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.neuropharm.2015.01.017","volume":"93","author":"A Rojas","year":"2015","unstructured":"Rojas A, Ganesh T, Lelutiu N, Gueorguieva P, Dingledine R (2015) Inhibition of the prostaglandin EP2 receptor is neuroprotective and accelerates functional recovery in a rat model of organophosphorus induced status epilepticus. Neuropharmacology 93:15\u201327. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.01.017","journal-title":"Neuropharmacology"},{"key":"765_CR59","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neuro.2020.12.010","volume":"83","author":"A Rojas","year":"2021","unstructured":"Rojas A, McCarren HS, Wang J, Wang W, Abreu-Melon J, Wang S, McDonough JH, Dingledine R (2021) Comparison of neuropathology in rats following status epilepticus induced by diisopropylfluorophosphate and Soman. Neurotoxicology 83:14\u201327. https:\/\/doi.org\/10.1016\/j.neuro.2020.12.010","journal-title":"Neurotoxicology"},{"key":"765_CR60","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.neuro.2022.04.010","volume":"91","author":"A Rojas","year":"2022","unstructured":"Rojas A, Abreu-Melon J, Wang S, Dingledine R (2022) Time-dependent neuropathology in rats following organophosphate-induced status epilepticus. Neurotoxicology 91:45\u201359. https:\/\/doi.org\/10.1016\/j.neuro.2022.04.010","journal-title":"Neurotoxicology"},{"issue":"2","key":"765_CR61","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1124\/jpet.123.001820","volume":"388","author":"EJ Shah","year":"2024","unstructured":"Shah EJ, Grunwald WC Jr., Garrett TL, Brown TL, Cool DR (2024) Sarin-Induced neuroinflammation in mouse brain is attenuated by the caspase inhibitor Q-VD-OPh. J Pharmacol Exp Ther 388(2):367\u2013375. https:\/\/doi.org\/10.1124\/jpet.123.001820","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"765_CR62","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1124\/jpet.123.001747","volume":"388","author":"T Singh","year":"2024","unstructured":"Singh T, Ramakrishnan S, Wu X, Reddy DS (2024) Sex differences in organophosphate model of Benzodiazepine-Refractory status epilepticus and neuronal damage. J Pharmacol Exp Ther 388(2):313\u2013324. https:\/\/doi.org\/10.1124\/jpet.123.001747","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"765_CR63","doi-asserted-by":"publisher","first-page":"e0234967","DOI":"10.1371\/journal.pone.0234967","volume":"15","author":"A Sugiyama","year":"2020","unstructured":"Sugiyama A, Matsuoka T, Sakamune K, Akita T, Makita R, Kimura S, Kuroiwa Y, Nagao M, Tanaka J (2020) The Tokyo subway sarin attack has long-term effects on survivors: A 10-year study started 5 years after the terrorist incident. PLoS ONE 15(6):e0234967. https:\/\/doi.org\/10.1371\/journal.pone.0234967","journal-title":"PLoS ONE"},{"issue":"10","key":"765_CR64","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1345\/aph.1E068","volume":"38","author":"MA Summers","year":"2004","unstructured":"Summers MA, Moore JL, McAuley JW (2004) Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy. Annals Pharmacotherapy 38(10):1631\u20131634. https:\/\/doi.org\/10.1345\/aph.1E068","journal-title":"Annals Pharmacotherapy"},{"issue":"10","key":"765_CR65","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.2741\/3481","volume":"14","author":"J Tattersall","year":"2009","unstructured":"Tattersall J (2009) Seizure activity post organophosphate exposure. Front Biosci (Landmark Ed) 14(10):3688\u20133711. https:\/\/doi.org\/10.2741\/3481","journal-title":"Front Biosci (Landmark Ed)"},{"key":"765_CR66","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1528-1167.2012.03622.x","volume":"4","author":"E Trinka","year":"2012","unstructured":"Trinka E, Hofler J, Zerbs A (2012) Causes of status epilepticus. Epilepsia 53 Suppl 4:127\u2013138. https:\/\/doi.org\/10.1111\/j.1528-1167.2012.03622.x","journal-title":"Epilepsia 53 Suppl"},{"key":"765_CR67","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cotox.2021.04.002","volume":"26","author":"YH Tsai","year":"2021","unstructured":"Tsai YH, Lein PJ (2021) Mechanisms of organophosphate neurotoxicity. Curr Opin Toxicol 26:49\u201360. https:\/\/doi.org\/10.1016\/j.cotox.2021.04.002","journal-title":"Curr Opin Toxicol"},{"key":"765_CR68","doi-asserted-by":"publisher","unstructured":"Vasanthi SS, Massey N, Meyer C, Wang C, Thippeswamy T (2025) Diet-incorporated saracatinib, a Src tyrosine kinase inhibitor, counter acts diisopropylfluorophosphate (DFP)-induced chronic neurotoxicity in the rat model. Biomed Pharmacother 189:118234.\u00a0https:\/\/doi.org\/10.1016\/j.biopha.2025.118234","DOI":"10.1016\/j.biopha.2025.118234"},{"issue":"5","key":"765_CR69","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/0028-3908(88)90126-8","volume":"27","author":"A Vezzani","year":"1988","unstructured":"Vezzani A, Wu HQ, Stasi MA, Angelico P, Samanin R (1988) Effect of various calcium channel blockers on three different models of limbic seizures in rats. Neuropharmacology 27(5):451\u2013458. https:\/\/doi.org\/10.1016\/0028-3908(88)90126-8","journal-title":"Neuropharmacology"},{"key":"765_CR70","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3389\/fnins.2016.00590","volume":"10","author":"JR Voorhees","year":"2016","unstructured":"Voorhees JR, Rohlman DS, Lein PJ, Pieper AA (2016) Neurotoxicity in preclinical models of occupational exposure to organophosphorus compounds. Front Neurosci 10:590. https:\/\/doi.org\/10.3389\/fnins.2016.00590","journal-title":"Front Neurosci"},{"issue":"2","key":"765_CR71","first-page":"122","volume":"88","author":"J Weaver-Agostoni","year":"2013","unstructured":"Weaver-Agostoni J (2013) Cluster headache. Am Fam Physician 88(2):122\u2013128","journal-title":"Am Fam Physician"},{"issue":"6","key":"765_CR72","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1161\/HYP.0000000000000065","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr., Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA, Sr., Williamson JD, Wright JT Jr. (2018) Prevention, Detection, Evaluation, and management of high blood pressure in adults: A report of the American college of Cardiology\/American heart association task force on clinical practice guidelines. Hypertension 71(6):e13\u2013e115. https:\/\/doi.org\/10.1161\/HYP.0000000000000065. 2017 ACC\/ AHA\/ AAPA\/ ABC\/ ACPM\/ AGS\/ APhA\/ ASH\/ ASPC\/ NMA\/ PCNA Guideline for the","journal-title":"Hypertension"},{"key":"765_CR73","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.cortex.2015.08.022","volume":"74","author":"RF White","year":"2016","unstructured":"White RF, Steele L, O\u2019Callaghan JP, Sullivan K, Binns JH, Golomb BA, Bloom FE, Bunker JA, Crawford F, Graves JC, Hardie A, Klimas N, Knox M, Meggs WJ, Melling J, Philbert MA, Grashow R (2016) Recent research on Gulf war illness and other health problems in veterans of the 1991 Gulf war: effects of toxicant exposures during deployment. Cortex 74:449\u2013475. https:\/\/doi.org\/10.1016\/j.cortex.2015.08.022. Epub 2015 Sep 25","journal-title":"Cortex"},{"issue":"2","key":"765_CR74","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1124\/jpet.117.247106","volume":"367","author":"X Wu","year":"2018","unstructured":"Wu X, Kuruba R, Reddy DS (2018) Midazolam-Resistant seizures and brain injury after acute intoxication of Diisopropylfluorophosphate, an organophosphate pesticide and surrogate for nerve agents. J Pharmacol Exp Ther 367(2):302\u2013321. https:\/\/doi.org\/10.1124\/jpet.117.247106","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"765_CR75","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1528-1157.1994.tb02458.x","volume":"35","author":"JN Wurpel","year":"1994","unstructured":"Wurpel JN, Iyer SN (1994) Calcium channel blockers verapamil and nimodipine inhibit kindling in adult and immature rats. Epilepsia 35(2):443\u2013449. https:\/\/doi.org\/10.1111\/j.1528-1157.1994.tb02458.x","journal-title":"Epilepsia"},{"issue":"6","key":"765_CR76","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.14336\/AD.2019.0228","volume":"10","author":"X Zhang","year":"2019","unstructured":"Zhang X, Chen S, Lu K, Wang F, Deng J, Xu Z, Wang X, Zhou Q, Le W, Zhao Y (2019) Verapamil ameliorates motor neuron degeneration and improves lifespan in the SOD1(G93A) mouse model of ALS by enhancing autophagic flux. Aging Dis 10(6):1159\u20131173. https:\/\/doi.org\/10.14336\/AD.2019.0228","journal-title":"Aging Dis"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-025-00765-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12640-025-00765-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-025-00765-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T22:01:40Z","timestamp":1767218500000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12640-025-00765-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,18]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["765"],"URL":"https:\/\/doi.org\/10.1007\/s12640-025-00765-z","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"type":"print","value":"1029-8428"},{"type":"electronic","value":"1476-3524"}],"subject":[],"published":{"date-parts":[[2025,10,18]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were approved and in accordance with the guidelines and regulations set by the VCU Institutional Animal Care and Use Committee (protocol AM10039), and the National Institutes of Health guide for the care and use of laboratory animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"41"}}